Research programme: ID4-based cancer therapeutics - Immusol
Latest Information Update: 22 Jul 2010
At a glance
- Originator Immusol
- Class Monoclonal antibodies; Small molecules
- Mechanism of Action Genetic transcription inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Ovarian cancer
Most Recent Events
- 24 Aug 2007 This programme seems to still be in active development
- 02 Apr 2001 Preclinical development for Breast cancer in USA (Unknown route)
- 02 Apr 2001 Preclinical development for Ovarian cancer in USA (Unknown route)